Global life sciences compliance specialist GxPi has appointed Ian Shott as chairman.
Shott is an experienced international business leader with a proven history of growing and transforming businesses to deliver exceptional results. Over the last 25 years he has led global businesses for AstraZeneca, Lonza, Rhodia and Chirex. He is currently president of AMRI Europe.
Shott said he would be looking to leverage his knowledge and international network to accelerate business development and sustainable growth at GxPi, which is headquartered in Nottingham, UK.
‘Having been a customer of the company in the past, I know just how good GxPI is at providing excellent, timely and cost effective solutions and how it will benefit from increasing market awareness both in the UK and abroad,’ he said.
Keith Williams, ceo at GxPi, added: ‘In the last two years GxPi has gone from strength to strength, developing innovative products and tailored services which have achieved great outcomes for our high profile clients. With Ian as chairman, we look forward to further success based around exciting developments in our service offering and our x-docstm and x-traintm products.’
